PharmD Candidate 2025
University of South Carolina College of Pharmacy - Columbia, SC
Disclosure(s): No financial relationships to disclose
Kendall Kerr is a third-year student pharmacist at the University of South Carolina College of Pharmacy. For the past two years, she has investigated the effects of CDK8 inhibition on ER+, HER2+, and Triple Negative cancer proliferation in vivo. Outside of the lab, Kendall serves as the APhA-ASP Chapter President at the University of South Carolina, a Junior Board Member for the South Carolina Pharmacy Association, and an active member of Rho Chi and Phi Lambda Sigma.